Singapore markets close in 6 hours 56 minutes
Straits Times Index
3,304.15 +7.26 (+0.22%) Nikkei
38,236.07 -37.98 (-0.10%) Hang Seng
18,518.28 +311.15 (+1.71%) FTSE 100
8,172.15 +50.91 (+0.63%) Bitcoin USD
59,302.41 +2,084.46 (+3.64%) CMC Crypto 200
1,281.08 +10.33 (+0.81%)
I-MAB (0VY.DU)
Dusseldorf - Dusseldorf Delayed price. Currency in EUR
Add to watchlist
At close: 07:30PM CEST
| Previous close | 1.6500 |
| Open | 1.6200 |
| Bid | 1.6200 x N/A |
| Ask | 1.6700 x N/A |
| Day's range | 1.6100 - 1.6400 |
| 52-week range | 1.6100 - 1.6800 |
| Volume | |
| Avg. volume | 0 |
| Market cap | N/A |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | 14 Mar 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Thomson Reuters StreetEvents
Q1 2024 Summit Therapeutics Inc Earnings Call
Q1 2024 Summit Therapeutics Inc Earnings Call
PR NewswireI-MAB Filed 2023 Annual Report on Form 20-F
I-Mab (the "Company") (NASDAQ: IMAB), a U.S.-based, global biotech company, exclusively focused on the development and potential commercialization of highly differentiated immunotherapies for the treatment of cancer, today announced that it has filed its annual report on Form 20-F for the year ended December 31, 2023 with the U.S. Securities and Exchange Commission ("SEC") on April 30, 2024.
© 2024 Yahoo. All rights reserved.